The retinol (vitamin A) market is set to grow at a steady pace with a compounded annual growth rate (CAGR) of 4.8% during the forecast period from 2018 to 2026. Retinol is enlisted in the World Health Organization (WHO) list of essential medicines.

Vaccines plays a significant role in prevention and control of different forms of infectious diseases. In the previous years, killed or attenuated vaccines were used, while gradually transitioning to recombinant subunit approach in the last two decades.

The global H2-receptor antagonists (H2RA) market is projected to grow at a higher CAGR within the forecast period from 2018 to 2026. H2-receptor antagonists play a very important role in preventing the secretion of gastric acid and treating duodenal ulcers, peptic ulcers, and esophageal ulcers. There is a vast range of H2RA products available in the market in the form of tablets, solution, and injectables and so on, which can be easily available through prescriptions or over-the-counter (OTC) channel.

The government health departments worldwide are actively seeking to achieve the welfare of the people and society by primarily focusing on the extending life expectancy, quality of life, free distribution of medications and so on. Rising prevalence of chronic diseases, and the corresponding increasing drug discovery and development studies performed by major pharmaceutical manufacturers and research organizations are driving the preventive healthcare technologies, products and services market.

Prebiotics are the non- digestible functional ingredients that selectively stimulate the growth of favorable bacteria’s in the gut of the host. Prebiotics facilitate the immune system thereby improving animal health.The market for prebiotics in animal feed is growing on the back of rising meat consumption. Meat and its products is considered as one of the major source of proteins, vitamins and mineralswhich are essential for growth and development.

Prebiotics market projected to exhibit the CAGR of 10.8% during the forecast period from 2018 to 2026. Prebiotics are functional ingredients that stimulates the growth of favorable bacteria’s present in the gut to facilitate digestion system. Prebiotics also facilitate the immune system, mitigate the risk of cardiovascular disease, and helps in improving gut health, thereby improving overall health of the host.

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. Polycystic ovarian syndrome (PCOS) therapeutics market is rapidly growing due to factors such as growing prevalence, changing lifestyle pattern, early diagnosis and significant unmet needs.

The global pneumococcal vaccines market held US$ 7,108.7 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.1% during the forecast period from 2018 to 2026. Pneumococcal diseases are one of the leading cause of serious illness globally resulting in high number of hospitalization every year.

Phospholipase enzyme market is projected to reach US$ 482.4 Mn by 2026 with 7.0% CAGR during the forecast period from 2018 to 2026. In 2017, North America held the largest value share in the global phospholipase enzyme market. Asia Pacific is projected to be the fastest growing region between 2018 and 2026.

The photodynamic therapy market is set to grow at an impressive rate with a compounded annual growth rate (CAGR) of 5.7% during the forecast period from 2018 to 2026. As per the statistics provided by World Health Organization (WHO), currently 2 to 3 million non-melanoma and 132,000 melanoma skin cancer occurs throughout the globe annually.

The plasma fractionation market is set to reach from US$ 18,099.5 Mn in 2017 to US$ 33,386.6 Mn by 2026 at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2018 to 2026. Plasma fractionation is utilized for achieving large quantities of purified protein from human plasma. Researchers have been focusing diligently in understanding the role and significance of plasma derived proteins in treating chronic ailments and autoimmune diseases. Increasing demand for biologics and increasing healthcare expenditure for drug development activities together drive the plasma fractionation market growth.

The Contract Development and Manufacturing Organization (CDMO) industry had begun decades ago as a niche business by offering specialty services and manufacturing capacities to pharmaceutical companies. The advent of CDMOs was mainly attributed to the failures of pharmaceutical companies due to challenged competencies and financial constraints.

Thin film drugs have been identified as the alternative approach to the conventional dosage forms. Oral thin films are thin, flexible films of drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and improved bioavailability for drugs. The oral thin film are mostly used for the geriatric, pediatric and bedridden patient who are unable to intake the solid form of the drug. Rising demand for efficient drug delivery route and its acceptability in the region would further drive the thin film drug manufacturing market in the future.

Orthopedic soft tissue repair products are used for reinforcement of weak, damaged or ruptured soft tissue. The growth of this market is mainly contributed by factors such as easy availability of novel products, increasing incidence of sports-related injuries, significant growth in highly vulnerable geriatric population.

The genital herpes treatment drugs market will be featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2018 to 2026. According to the latest research citing’s published by World Health Organization (WHO), approximately two-thirds of the global population under 50 years of age is infected with herpes simplex virus type 1 (HSV-1).

The generic oncology drugs market is set to reach from US$ 17,151.0 Mn in 2017 to US$ 29,222.5 Mn by 2026 representing undeviated growth at a compounded annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO) in 2018, 9.6 million people worldwide have been estimated to be dead due to cancer. It is considered as the second leading cause of death, researchers are of the opinion that approximately 30% cancer deaths can be prevented by avoiding risk factors such as alcohol consumption, tobacco smoking, early diagnosis etc.

The interventional pulmonology market is set to reach from US$ 1,145.6 Mn in 2017 to US$ 1,747.0 Mn by 2026 highlighting unswerving growth at a compounded annual growth rate (CAGR) of 4.8% during the forecast period from 2018 to 2026. As per the statistics provided by World Health Organization (WHO), in 2018 approximately 2.09 million people died due to lung cancer. Tobacco smoking is the leading causes of formation of malignant tumours and neoplasms in the lungs. Interventional pulmonology is a relatively new field which has gained tremendous attraction in the last decade which employs sophisticated tools to perform diagnosis and treatment of various pulmonary disorders. Apart from pulmonologist cardiothoracic surgeons also routinely perform interventional pulmonology procedures.

This report titled “Iron Supplements Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the trends in the global iron supplements market along with the market size and forecast for the duration 2015 to 2025. The said research study incorporates in-depth analysis of multiple market segments based on form, application and geographical distribution.

Kidney cancer is the most common cancer in the world around 63,990 new cases are estimated to be in 2017. Among the primary kidney cancer, renal parenchymal cancer is the most common estimating around 80-90% and it is the most complex to treat. The chances of developing cancer is about 1 in 63 in lifetime, with higher risk in men than women.

Krill are small, up to 6 cm, shrimplike shellfish at the base of the ocean’s food chain. Including 85 species of krill, the total estimated biomass of between 400 Mn and 600 Mn tones in 2016-17. For claimed health benefits of krill oil, including the management and treatment of conditions, such as hyperlipidemia, inflammation, and arthritis, there has been a noticeable increase in research and promotion of krill oil in recent years.